Nov 10, 2019
Dr. Ge Li Awarded "CEO of the Year" at CPhI Worldwide 2019
Nov 06, 2019
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies
Oct 27, 2019
WuXi STA's Jinshan Facility Passes EMA Inspection
Oct 10, 2019
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules
Sep 09, 2019
Xinhua Silk Road: World IoT Expo 2019 commences in Wuxi, east China
Sep 09, 2019
2019 World Internet of Things (IoT) Exposition is held in Wuxi
Sep 07, 2019
HCmed Innovations joins Wuxi International Life Science Innovation Park supported by AstraZeneca China
Sep 03, 2019
WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery
Jul 23, 2019
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
Jun 29, 2019
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies
Jun 26, 2019
NetLinkz announces China revenue from China Telecom Wuxi Pilot
Jun 20, 2019
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
Jun 11, 2019
WuXi NextCODE Clarifications to Public Letter Sent to Department of Health and Human Services Acting Inspector General Joanne M. Chiedi
Jun 04, 2019
WuXi Biologics Hosts Successful Inaugural Investor Day
May 20, 2019
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
May 16, 2019
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu
May 05, 2019
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
Apr 16, 2019
I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs
Mar 27, 2019
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection
Mar 25, 2019
WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC